Aktuelles

Safe the date: 11th primary hyperoxaluria workshop, 27.6.-28.6.2014, Chicago, IL, USA

Registration:

Professionals
Patients/Families


 

Publikationen 2011 Hyperoxalurie Köln

1. Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011 Dec;80(12):1278-91. doi: 10.1038/ki.2011.336. Epub 2011 Sep 28.

2. Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney Int. 2011 Dec;80(11):1146-58. doi: 10.1038/ki.2011.287. Epub 2011 Aug 24.

3. Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis. Am J Kidney Dis. 2011 Sep;58(3):453-5. Epub 2011 Jun 25.

4. Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant. 2011 Nov;26(11):3609-15. Epub 2011 Apr 2.

5. Beck BB, Habbig S, Dittrich K, Stippel D, Kaul I, Koerber K, Goebel H, Salido EC, Kemper M, Meyburg J, Hoppe B. Liver cell transplantation in severe infantile oxalosis – a possible bridging procedure? Nephrol Dial Transplant, in press.

Ausgewählte Literatur

Hoppe B, Beck BB, Milliner DS. The primary hyperoxalurias. Kidney Int 2009; 75(12): 1264-1271.

Blostosky R, Seboun E, Idelson GH, et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Gen 2010; 87: 392-399.

Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG, Giachino D, Owen T, Robbiano A, Salido E, Waterham H, Rumsby G. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat 2009;30(6):910-7.

Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Frontiers in Biosciences 2003;8:e437-443

Belostotsky R, Seboun E, Idelson GH, et al. Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Gen 2011; 88: 193-200

Monico CG, Rossetti S, Belostosky R, Cogal AG, Herges RM, Seide BM, Olson JB, Bergstrahl EJ, Williams HJ, Haley WE, Frishberg J, Milliner DS. Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol, 2011; 6: 2289-2295